Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne virus causing serious infectious disease with a high case-fatality of up to 50% in severe cases. Currently, no effective drug has been approved for the treatment of SFTSV infection. Here, we performed a high-throughp...
Main Authors: | Shufen Li, Meidi Ye, Yuanqiao Chen, Yulan Zhang, Jiachen Li, Wei Liu, Hao Li, Ke Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.735223/full |
Similar Items
-
Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA
by: Roger S. Nasci, et al.
Published: (2014-02-01) -
Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA
by: Zheng Xing, et al.
Published: (2014-02-01) -
Therapeutic potential of toosendanin: Novel applications of an old ascaris repellent as a drug candidate
by: Minghao Hu, et al.
Published: (2023-11-01) -
Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3
by: Ye Wu, et al.
Published: (2023-11-01) -
The Polarity of an Amino Acid at Position 1891 of Severe Fever with Thrombocytopenia Syndrome Virus L Protein Is Critical for the Polymerase Activity
by: Kisho Noda, et al.
Published: (2020-12-01)